Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020

Abstract Background The use of opioids has increased dramatically over the past several years in Israel. The aim of this study was to explore the trends of opioid consumption in Israel over a decade (2010–2020) stratified by socioeconomic status (SES), residence in the periphery, and ethnic backgrou...

Full description

Bibliographic Details
Main Authors: Limor Adler, Bar Cohen, Shirley Shapiro Ben Daviv, Ori Liran, Daniella Rahamim-Cohen, Afif Nakhleh, Arnon Shahar, Joseph Azuri
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Israel Journal of Health Policy Research
Subjects:
Online Access:https://doi.org/10.1186/s13584-024-00598-9
_version_ 1827321465009078272
author Limor Adler
Bar Cohen
Shirley Shapiro Ben Daviv
Ori Liran
Daniella Rahamim-Cohen
Afif Nakhleh
Arnon Shahar
Joseph Azuri
author_facet Limor Adler
Bar Cohen
Shirley Shapiro Ben Daviv
Ori Liran
Daniella Rahamim-Cohen
Afif Nakhleh
Arnon Shahar
Joseph Azuri
author_sort Limor Adler
collection DOAJ
description Abstract Background The use of opioids has increased dramatically over the past several years in Israel. The aim of this study was to explore the trends of opioid consumption in Israel over a decade (2010–2020) stratified by socioeconomic status (SES), residence in the periphery, and ethnic background. Methods This cross-sectional study included all adult Maccabi Healthcare Services (MHS) patients who filled at least one prescription for opioids during the past decade. In order to standardize dosages and compare different opioid medications, we used the Morphine Milligram Equivalent (MME) conversion factor. We performed The Mann–Kendall test with autocorrelation correction to assess each trend. We then checked the differences between the trends with the Mann–Whitney test (for periphery) and the Kruskal Wallis (for SES and ethnic background). Results Between the years 2010–2020, 261,270 MHS members met the study's inclusion criteria. The proportions of opioids consumption were 23.9/1000 patients in 2010 and 27.6/1000 patients in 2020, representing a 15% increase. The average daily consumption of opioids was 4.6 and 10.5 MME in 2010 and 2020, respectively, an increase of 227%. The daily MME during 2020 was higher for residents of the periphery compared to non-periphery residents (daily MME of 14.0 compared to 10.1, respectively). Average daily MME increased gradually during the study period for all levels of SES; the values were highest for the low SES group and the lowest for the high SES group (daily MME in 2020 for the lowest, middle, and high SES groups were 15.2 vs. 11.8 vs. 6.7 respectively). Conclusions This study highlights that the primary concern in the increase of opioid use is the increasing dosages. The increase in the number of patients using opioids is also significant but to a minor extent. These phenomena disproportionately impact vulnerable populations. Education programs should be offered to physicians regarding the possible harms of long-term use of opioids. These programs should emphasize the risk factors associated with the development of opioid use disorder (OUD) and the caution needed when increasing dosages or switching to higher-potency drugs. Pain clinics and centers for rehabilitation for patients with chronic pain or OUD should be available, not only in central areas but also in the periphery of the country. These clinics and centers should use a holistic approach and a multidisciplinary team that includes specialists in pain and addiction. They should be financially accessible for patients from low SES group and provide solutions in multiple languages.
first_indexed 2024-04-25T01:06:38Z
format Article
id doaj.art-fc2ec35cf7d148849326459b4008aeb5
institution Directory Open Access Journal
issn 2045-4015
language English
last_indexed 2024-04-25T01:06:38Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Israel Journal of Health Policy Research
spelling doaj.art-fc2ec35cf7d148849326459b4008aeb52024-03-10T12:14:36ZengBMCIsrael Journal of Health Policy Research2045-40152024-03-011311910.1186/s13584-024-00598-9Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020Limor Adler0Bar Cohen1Shirley Shapiro Ben Daviv2Ori Liran3Daniella Rahamim-Cohen4Afif Nakhleh5Arnon Shahar6Joseph Azuri7Health Division, Maccabi Healthcare ServicesDepartment of Family Medicine, Faculty of Medicine, Tel Aviv UniversityHealth Division, Maccabi Healthcare ServicesHealth Division, Maccabi Healthcare ServicesHealth Division, Maccabi Healthcare ServicesDiabetes and Endocrinology Clinic, Maccabi Healthcare ServicesHealth Division, Maccabi Healthcare ServicesHealth Division, Maccabi Healthcare ServicesAbstract Background The use of opioids has increased dramatically over the past several years in Israel. The aim of this study was to explore the trends of opioid consumption in Israel over a decade (2010–2020) stratified by socioeconomic status (SES), residence in the periphery, and ethnic background. Methods This cross-sectional study included all adult Maccabi Healthcare Services (MHS) patients who filled at least one prescription for opioids during the past decade. In order to standardize dosages and compare different opioid medications, we used the Morphine Milligram Equivalent (MME) conversion factor. We performed The Mann–Kendall test with autocorrelation correction to assess each trend. We then checked the differences between the trends with the Mann–Whitney test (for periphery) and the Kruskal Wallis (for SES and ethnic background). Results Between the years 2010–2020, 261,270 MHS members met the study's inclusion criteria. The proportions of opioids consumption were 23.9/1000 patients in 2010 and 27.6/1000 patients in 2020, representing a 15% increase. The average daily consumption of opioids was 4.6 and 10.5 MME in 2010 and 2020, respectively, an increase of 227%. The daily MME during 2020 was higher for residents of the periphery compared to non-periphery residents (daily MME of 14.0 compared to 10.1, respectively). Average daily MME increased gradually during the study period for all levels of SES; the values were highest for the low SES group and the lowest for the high SES group (daily MME in 2020 for the lowest, middle, and high SES groups were 15.2 vs. 11.8 vs. 6.7 respectively). Conclusions This study highlights that the primary concern in the increase of opioid use is the increasing dosages. The increase in the number of patients using opioids is also significant but to a minor extent. These phenomena disproportionately impact vulnerable populations. Education programs should be offered to physicians regarding the possible harms of long-term use of opioids. These programs should emphasize the risk factors associated with the development of opioid use disorder (OUD) and the caution needed when increasing dosages or switching to higher-potency drugs. Pain clinics and centers for rehabilitation for patients with chronic pain or OUD should be available, not only in central areas but also in the periphery of the country. These clinics and centers should use a holistic approach and a multidisciplinary team that includes specialists in pain and addiction. They should be financially accessible for patients from low SES group and provide solutions in multiple languages.https://doi.org/10.1186/s13584-024-00598-9Opioid usageSocioeconomic statusPeripherial residencyArab populationOrthodox-JewsMinorities
spellingShingle Limor Adler
Bar Cohen
Shirley Shapiro Ben Daviv
Ori Liran
Daniella Rahamim-Cohen
Afif Nakhleh
Arnon Shahar
Joseph Azuri
Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020
Israel Journal of Health Policy Research
Opioid usage
Socioeconomic status
Peripherial residency
Arab population
Orthodox-Jews
Minorities
title Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020
title_full Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020
title_fullStr Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020
title_full_unstemmed Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020
title_short Use of prescription opioids in Israel and socio-economic correlations between 2010 and 2020
title_sort use of prescription opioids in israel and socio economic correlations between 2010 and 2020
topic Opioid usage
Socioeconomic status
Peripherial residency
Arab population
Orthodox-Jews
Minorities
url https://doi.org/10.1186/s13584-024-00598-9
work_keys_str_mv AT limoradler useofprescriptionopioidsinisraelandsocioeconomiccorrelationsbetween2010and2020
AT barcohen useofprescriptionopioidsinisraelandsocioeconomiccorrelationsbetween2010and2020
AT shirleyshapirobendaviv useofprescriptionopioidsinisraelandsocioeconomiccorrelationsbetween2010and2020
AT oriliran useofprescriptionopioidsinisraelandsocioeconomiccorrelationsbetween2010and2020
AT daniellarahamimcohen useofprescriptionopioidsinisraelandsocioeconomiccorrelationsbetween2010and2020
AT afifnakhleh useofprescriptionopioidsinisraelandsocioeconomiccorrelationsbetween2010and2020
AT arnonshahar useofprescriptionopioidsinisraelandsocioeconomiccorrelationsbetween2010and2020
AT josephazuri useofprescriptionopioidsinisraelandsocioeconomiccorrelationsbetween2010and2020